Purdue and Sackler family agree to $7.4bn opioid settlement with US states
The Sackler family and the opioid maker they founded, Purdue Pharma, have together agreed to pay $7.4bn to settle liabilities over their roles in the opioid crisis, ending months of negotiations after a previous deal fell apart.
Purdue & Sackler Family Agree $7.4B OxyContin Settlement
The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement to resolve federal claims brought by attorneys general from 15 states. Announced by New York Attorney General Letitia James,
Sackler family, Purdue Pharma agree to pay $7.4B to settle opioid suit by 15 states
The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states.
Delaware slated to receive over $27M in settlement with Purdue Pharma, Sackler family
A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half of what was originally anticipated before a Supreme Court decision put settlement funds in limbo last year.
Purdue Pharma, Sackler family agree to $7.4 billion opioid settlement
Purdue Pharma and the Sackler family have agreed to increase by over $1 billion after the Supreme Court overturned a prior settlement in 2024.
Sackler family and Purdue agree to pay Utah $57 million for opioid damages
Prescription opioid overdoses have killed thousands of Utahns. A new settlement puts a price tag on their lives and could bring "justice" to their families."
Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s Sup | The billionaire family behind former OxyContin maker Purdue Pharma was denied a bankruptcy protection deal in a high-profile Supreme Court ruling last summer.
Sackler family and Purdue Pharma to pay €7bn as part of opioid accord
Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s role in opioid epidemic
Sackler, Purdue Pharma $7 Billion Lawsuit: Who's Entitled to Payment
The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma, over their actions leading up to the opioid crisis, which has killed several hundreds of thousands of people in the last two decades.
Purdue Pharma owners strike new $6.5 billion deal in opioid case
The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.
Purdue and Sackler family agree $7.4bn opioid settlement
Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an increase of more than $1bn on a previous settlement that was rejected in 2024 by the US Supreme Court, according to news agencies AP and Reuters.
Sackler Family’s Net Worth: How Much Money They’re Worth Now
The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.
Hosted on MSN16h
New $7.4B Sackler Deal Has Unusual Condition
A new settlement has been reached on lawsuits against Oxycontin maker Purdue Pharma and the Sackler family that owns it, seven months after the Supreme Court rejected a $6 billion deal. The $7.4 ...